Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Emergent BioSolutions Inc. Common Stock
(NY:
EBS
)
12.51
+0.15 (+1.21%)
Official Closing Price
Updated: 7:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent BioSolutions Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
↗
December 30, 2024
Via
Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
↗
December 30, 2024
Via
Benzinga
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
↗
December 30, 2024
Via
Benzinga
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
December 30, 2024
Via
Benzinga
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
December 16, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions
↗
December 09, 2024
UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International...
Via
Benzinga
Why Emergent BioSciences Stock Plummeted Today
↗
December 03, 2024
Via
The Motley Fool
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement
↗
November 22, 2024
Via
Benzinga
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
↗
November 18, 2024
The week kicks off amidst significant market movements shaped by geopolitical and policy developments.
Via
Talk Markets
Topics
Stocks / Equities
After Trump's Win, It's Time To Take Profits On Gold
↗
November 11, 2024
Via
Benzinga
Topics
Government
Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise
↗
November 07, 2024
The U.S. overdose crisis and its racial disparities were overlooked in the election, as Black and Indigenous Americans face rising death rates.
Via
Benzinga
Topics
Death
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
↗
November 07, 2024
Emergent BioSolutions stock rises on mixed Q3 results, improved 2024 guidance, and news of a new trial for mpox treatment in Africa led by the CDC.
Via
Benzinga
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
↗
November 07, 2024
Via
Benzinga
Gold Gains 1%; Halliburton Posts Weak Q3 Results
↗
November 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 07, 2024
Via
Benzinga
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
↗
November 07, 2024
Via
Benzinga
The Post-Trump Victory Trade
↗
November 07, 2024
The Trump Trade.
Via
Benzinga
Topics
Government
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 07, 2024
Via
Benzinga
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
↗
November 07, 2024
Via
Benzinga
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
↗
November 07, 2024
EBS earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
November 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
November 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
November 04, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
October 23, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
October 08, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
What's Going On With Emergent BioSolutions Stock Wednesday?
↗
October 02, 2024
Emergent BioSolutions stock is trading higher after the company announced the closing of a $100 million asset-backed revolving loan facility.
Via
Benzinga
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
October 02, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 26, 2024
Via
Benzinga
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
September 26, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
↗
September 25, 2024
Emergent BioSolutions secures $400M in orders for smallpox and mpox products, receives FDA approval for ACAM2000's expanded use, and updates its 2024 revenue forecast while beating Q2 sales estimates.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
